logo
logo
Sign in

Opioid Use Disorder Treatment Market - Global In-Depth Study and Analysis 2023 to 2033

avatar
Ganesh Shinde
Opioid Use Disorder Treatment Market - Global In-Depth Study and Analysis 2023 to 2033

According to market projections, the global opioid use disorder treatment market is expected to reach an impressive valuation of US$ 3.07 billion in 2023 and is forecasted to expand at a CAGR of 10.5% during the forecast period, reaching US$ 8.4 billion by 2033. The providers and manufacturers of drug abuse treatment are focusing primarily on creating awareness among people and drug store owners about the harmful effects of drug abuse and the significance of seeking treatment. This approach helps to increase their customer base, leading to the expansion of the opioid use disorder treatment market. Various media, including television advertisements, newspapers, and information brochures, are being used effectively to raise awareness and curb the opioid abuse crisis.

The industry's expansion is also being fueled by collaborations between different organizations. For instance, in March 2016, GlaxoSmithKline partnered with 2morrow Inc., the developer of the SmartQuit app, to provide patches to smokers following the app plan. Similarly, in August 2013, the company agreed to distribute its generic version of Suboxon, Buprenorphine HCl and Naloxone HCl Dihydrate Sublingual Tablets (CIII), to addiction treatment centers through its collaboration with Amneal Pharmaceuticals LLC. These partnerships are expected to benefit the opioid use disorder treatment market in the long run.

Competitive Landscape

The Opioid use disorder treatment Market is competitive and consists of several major players. Major players are creating novel delivery systems for the treatment of opioid use disorder. This is expected to propel Opioid use disorder treatment market. The major players in the market are: Trevena, Opiate Pharmaceutical, Aphios, Kyowa kirin, Gamida-Cell, Novartis, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals, MediciNova, Alkermes, Inc., BioDelivery Sciences International, Inc.

Browse More Details@ https://www.futuremarketinsights.com/reports/opioid-use-disorder-treatment-market

Key Segments Profiled in the Opioid Use Disorder Treatment Market Survey

By Drug Type:

  • Romiplostim
  • Omidubicel
  • Nalmefene
  • Buprenorfine
  • Methadone
  • Naltrexone

By Route of Administration:

  • Oral
  • Parenteral

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies


collect
0
avatar
Ganesh Shinde
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more